肝硬化血氨相关肝性脑病的诊治思考

张亮; 李浩; 汤善宏

doi:10.3969/j.issn.1001-5256.2023.12.028

肝硬化血氨相关肝性脑病的诊治思考

DOI: 10.3969/j.issn.1001-5256.2023.12.028

西部战区总医院消化内科，成都 610083

基金项目:

四川省卫生健康委员会科研课题 (20PJ180)

利益冲突声明：本文不存在任何利益冲突。

作者贡献声明：张亮参与拟定写作思路及撰写文章；李浩参与指导撰写文章及论文修改；汤善宏负责拟定写作思路，指导撰写文章及最后定稿。

详细信息

通信作者:
汤善宏， shanhongtang@163.com （ORCID： 0000-0001-6652-2942）

计量
- 文章访问数: 301
- HTML全文浏览量: 101
- PDF下载量: 55
- 被引次数: 0
出版历程
- 收稿日期: 2023-04-08
- 录用日期: 2023-05-10
- 出版日期: 2023-12-12

Thoughts on the diagnosis and treatment of hepatic encephalopathy associated with blood ammonia in liver cirrhosis

Department of Gastroenterology，The General Hospital of Western Theater Command，Chengdu 610083，China

Research funding:

Research Project of Sichuan Provincial Health Commission (20PJ180)

More Information

Corresponding author: TANG Shanhong， shanhongtang@163.com （ORCID： 0000-0001-6652-2942）

摘要

摘要: 肝性脑病是肝硬化的严重并发症，可引起神经精神症状，如认知功能障碍和运动障碍等。超过30%的肝硬化患者会发生肝性脑病，给患者造成了巨大的经济负担，也给临床诊治带来了很多挑战。因此，早期发现和诊治是改善患者预后的关键。本文结合本中心的临床经验，从发病机制、时间维度、轻微型肝性脑病及脑部非器质性病变方面进行阐述，以期对肝硬化肝性脑病的临床诊治提供新的思路或策略。
- 肝硬化 /
- 肝性脑病 /
- 诊断
Abstract: Hepatic encephalopathy is a serious complication of liver cirrhosis and can cause neuropsychiatric symptoms such as cognitive impairment and motor impairment. More than 30% of patients with liver cirrhosis may develop hepatic encephalopathy， posing a huge economic burden to the health of patients and bringing many challenges to clinical diagnosis and treatment. Therefore， early identification， diagnosis， and treatment are the key to improving patient prognosis. Based on the clinical experience of our center， this article elaborates on hepatic encephalopathy from the aspects of pathogenesis， time dimension， minimal hepatic encephalopathy， and non-organic brain lesions， in order to provide new ideas or strategies for the diagnosis and treatment of hepatic encephalopathy in liver cirrhosis.
- Liver Cirrhosis /
- Hepatic Encephalopathy /
- Diagnosis

HTML全文

参考文献(24)

[1]	RAHIMI RS, BROWN KA, FLAMM SL, et al. Overt hepatic encephalopathy: Current pharmacologic treatments and improving clinical outcomes[J]. Am J Med, 2021, 134( 11): 1330- 1338. DOI: 10.1016/j.amjmed.2021.06.007.
[2]	Expert Committee on the Diagnosis and Treatment of Hepatic Encephalopathy. Expert consensus on diagnosis and treatment of hepatic encephalopathy[J]. Chin J Exp Clin Infect Dis Electron Version, 2009, 3( 4): 449- 473. 肝性脑病诊断治疗专家委员会. 肝性脑病诊断治疗专家共识[J/CD]. 中华实验和临床感染病杂志(电子版), 2009, 3( 4): 449- 473.
[3]	FIATI KENSTON SS, SONG X, LI Z, et al. Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy[J]. J Gastroenterol Hepatol, 2019, 34( 1): 31- 39. DOI: 10.1111/jgh.14408.
[4]	OCHOA-SANCHEZ R, TAMNANLOO F, ROSE CF. Hepatic encephalopathy: From metabolic to neurodegenerative[J]. Neurochem Res, 2021, 46( 10): 2612- 2625. DOI: 10.1007/s11064-021-03372-4.
[5]	WON SM, OH KK, GUPTA H, et al. The link between gut microbiota and hepatic encephalopathy[J]. Int J Mol Sci, 2022, 23( 16): 8999. DOI: 10.3390/ijms23168999.
[6]	STEPANOVA M, MISHRA A, VENKATESAN C, et al. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009[J]. Clin Gastroenterol Hepatol, 2012, 10( 9): 1034- 1041.e1. DOI: 10.1016/j.cgh.2012.05.016.
[7]	LIU JC, XU YT, JIANG BM. Novel insights into pathogenesis and therapeutic strategies of hepatic encephalopathy, from the gut microbiota perspective[J]. Front Cell Infect Microbiol, 2021, 11: 586427. DOI: 10.3389/fcimb.2021.586427.
[8]	JAFFE A, LIM JK, JAKAB SS. Pathophysiology of hepatic encephalopathy[J]. Clin Liver Dis, 2020, 24( 2): 175- 188. DOI: 10.1016/j.cld.2020.01.002.
[9]	AHMED Z, HASSAN M, ARIF SF, et al. Comparative efficacy of treatment options for the prevention of post-TIPS hepatic encephalopathy: A systematic review and network meta-analysis[J]. J Gastrointestin Liver Dis, 2023, 32( 1): 70- 76. DOI: 10.15403/jgld-4508.
[10]	SCHINDLER P, HEINZOW H, TREBICKA J, et al. Shunt-induced hepatic encephalopathy in TIPS: Current approaches and clinical challenges[J]. J Clin Med, 2020, 9( 11): 3784. DOI: 10.3390/jcm9113784.
[11]	DHANDA S, SANDHIR R. Blood-brain barrier permeability is exacerbated in experimental model of hepatic encephalopathy via MMP-9 activation and downregulation of tight junction proteins[J]. Mol Neurobiol, 2018, 55( 5): 3642- 3659. DOI: 10.1007/s12035-017-0521-7.
[12]	LI X, PARTOVI S, CORONADO WM, et al. Hepatic encephalopathy after TIPS placement: Predictive factors, prevention strategies, and management[J]. Cardiovasc Intervent Radiol, 2022, 45( 5): 570- 577. DOI: 10.1007/s00270-021-03045-3.
[13]	FIATI KENSTON SS, SONG X, LI Z, et al. Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy[J]. J Gastroenterol Hepatol, 2019, 34( 1): 31- 39. DOI: 10.1111/jgh.14408.
[14]	KROUPINA K, BÉMEUR C, ROSE CF. Amino acids, ammonia, and hepatic encephalopathy[J]. Anal Biochem, 2022, 649: 114696. DOI: 10.1016/j.ab.2022.114696.
[15]	THOMSEN KL, MACNAUGHTAN J, TRITTO G, et al. Clinical and pathophysiological characteristics of cirrhotic patients with grade 1 and minimal hepatic encephalopathy[J]. PLoS One, 2016, 11( 1): e0146076. DOI: 10.1371/journal.pone.0146076.
[16]	BERSAGLIERE A, RADUAZZO ID, SCHIFF S, et al. Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis[J]. Clin Neurophysiol, 2013, 124( 3): 492- 496. DOI: 10.1016/j.clinph.2012.08.014.
[17]	PISAREK W. Minimal hepatic encephalopathy-diagnosis and treatment[J]. Prz Gastroenterol, 2021, 16( 4): 311- 317. DOI: 10.5114/pg.2021.111389.
[18]	FERENCI P. Hepatic encephalopathy[J]. Gastroenterol Rep, 2017, 5( 2): 138- 147. DOI: 10.1093/gastro/gox013.
[19]	GAIRING SJ, MANGINI C, ZARANTONELLO L, et al. Prevalence of minimal hepatic encephalopathy in patients with liver cirrhosis: A multicenter study[J]. Am J Gastroenterol, 2023. DOI: 10.14309/ajg.0000000000002251.[Oline ahead of print]
[20]	CHANG YH, ZHOU XL, JING D, et al. Portal hypertension exacerbates intrahepatic portosystemic venous shunt and further induces refractory hepatic encephalopathy: A case report[J]. World J Clin Cases, 2021, 9( 2): 496- 501. DOI: 10.12998/wjcc.v9.i2.496.
[21]	LU JJ, LI Y, ZHANG C, et al. Metabolic changes of the reduction of manganese intake in the hepatic encephalopathy rat: NMR-and MS-based metabolomics study[J]. Biometals, 2022, 35( 5): 935- 953. DOI: 10.1007/s10534-022-00415-3.
[22]	HANGEL G, NIESS E, LAZEN P, et al. Emerging methods and applications of ultra-high field MR spectroscopic imaging in the human brain[J]. Anal Biochem, 2022, 638: 114479. DOI: 10.1016/j.ab.2021.114479.
[23]	SU YY, YANG GF, LU GM, et al. PET and MR imaging of neuroinflammation in hepatic encephalopathy[J]. Metab Brain Dis, 2015, 30( 1): 31- 45. DOI: 10.1007/s11011-014-9633-1.
[24]	KARANFILIAN BV, CHEUNG M, DELLATORE P, et al. Laboratory abnormalities of hepatic encephalopathy[J]. Clin Liver Dis, 2020, 24( 2): 197- 208. DOI: 10.1016/j.cld.2020.01.011.